Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

New Medical Devices research report from GlobalData is now available from Fast Market Research
 
May 17, 2011 - PRLog -- Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global tumor markers market. The report provides market landscape, competitive landscape and market trends information on the tumor markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

While tumor markers have been part of the global cancer diagnostics market since the 1960s, their popularity as therapeutic targets has only risen in the last few decades, primarily due to the increasing prevalence and mortality related to cancer. Cancer is currently the second leading cause of death in most developed countries of the world such as the US, the UK and so on, and is one of the most researched disease areas in the pharmaceutical and biotechnology industry. The global tumor markers market was estimated at $1 billion in 2010 and is expected to grow at a CAGR (compound annual growth rate) of over 6% till 2017. The tumor markers market is poised for rapid growth as researchers approach major technological breakthroughs in tumor diagnosis and therapy, the discovery of new specific antigens, and the genetic basis of cancer. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, the early detection of tumors, and monitoring biological responses to cancer therapy.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/159542_tumor_markers_global_pi...
------------------------------------------------------------

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
* Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
* Qualitative analysis of key market trends, market drivers, and restraints by each category within tumor markers market.
* The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
* Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Fujirebio Inc., bioMErieux SA and Beckman Coulter.


Reasons to buy

* Develop business strategies by understanding the trends and developments that are driving the tumor markers market globally.
* Design and develop your product development, marketing and sales strategies.
* Develop market-entry and market expansion strategies.
* Identify key players best positioned to take advantage of the emerging market opportunities.
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
* What's the next big thing in the tumor markers market landscape? - Identify, understand and capitalize.
* Make more informed business decisions from the insightful and in-depth analysis of the global tumor markers market and the factors shaping it.


Partial Table of Contents:

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Disease Overview: Cancer
3.1 Etiology
3.2 Types of cancers
3.2.1 Classification by Histology
3.2.2 Cancer Types by Site
3.3 Cancer Signs and Symptoms
3.4 Cancer Diagnosis
3.5 Epidemiology
4 Tumor Markers Overview
4.1 Tumor Markers: Technology Overview
4.1.1 Introduction
4.1.2 Types of Tumor Markers
4.1.3 Applications
5 Tumor Markers: Global Market Characterization
5.1 Tumor Markers Market, Global, Revenue ($m), Historic, 2003 - 2010
5.2 Tumor Markers Market, Global, Revenue ($m), Forecast, 2010 - 2017
5.3 Tumor Markers, Key Market Trends
5.3.1 Increasing Investments by Private Equity (PE) /Venture Capital (VC) Firms in Startups is Driving Innovation and Market Growth
5.3.2 Novel Tumor Markers Makes Diagnostic Test for Ovarian Cancer More Efficient
5.4 Tumor Markers, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
5.5 Tumor Markers Market, Opportunities and Unmet Needs
5.5.1 Opportunities: Highly Fragmented Market to Provide a Significant Opportunity for Big Tumor Marker Manufacturers
5.5.2 Unmet Needs
6 Tumor Markers Market, by Country, Revenue ($m), 2003 - 2017
6.1 Tumor Markers Market, The US, Revenue ($m), Historic, 2003-2010
6.2 Tumor Markers Market, The US, Revenue ($m), Forecast, 2010-2017
6.3 Tumor Markers Market, Canada, Revenue ($m), Historic, 2003-2010
6.4 Tumor Markers Market, Canada, Revenue ($m), Forecast, 2010-2017
6.5 Tumor Markers Market, The UK, Revenue ($m), Historic, 2003-2010
6.6 Tumor Markers Market, The UK, Revenue ($m), Forecast, 2010-2017
6.7 Tumor Markers Market, Germany, Revenue ($m), Historic, 2003-2010
6.8 Tumor Markers Market, Germany, Revenue ($m), Forecast, 2010-2017
6.9 Tumor Markers Market, France, Revenue ($m), Historic, 2003- 2010
6.10 Tumor Markers Market, France, Revenue ($m), Forecast, 2010-2017
6.11 Tumor Markers Market, Italy, Revenue ($m), Historic, 2003-2010
6.12 Tumor Markers Market, Italy, Revenue ($m), Forecast, 2010-2017
6.13 Tumor Markers Market, Spain, Revenue ($m), Historic, 2003-2010
6.14 Tumor Markers Market, Spain, Revenue ($m), Forecast, 2010-2017
6.15 Tumor Markers Market, Japan, Revenue ($m), Historic, 2003-2010

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1595...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Tumor, Marker, Cancer, Trial, Test, Clinical, 2010-2017, 2003-2010, Diagnostic, Pipeline
Industry:Medical, Health, Research
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share